Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/51149
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKahraman, Seda-
dc.contributor.authorErul, Enes-
dc.contributor.authorSeyyar, Mustafa-
dc.contributor.authorGümüşay, Özge-
dc.contributor.authorBayram, Ertuğrul-
dc.contributor.authorÇakan Demirel, Burçin-
dc.contributor.authorAcar, Ömer-
dc.contributor.authorAksoy, Sercan-
dc.contributor.authorBaytemur, Naziyet Kose-
dc.contributor.authorSahin, Elif-
dc.contributor.authorCabuk, Devrim-
dc.contributor.authorBasaran, Gül-
dc.contributor.authorPaydas, Semra-
dc.contributor.authorYaren, Arzu-
dc.contributor.authorGuven, Deniz Can-
dc.contributor.authorErdogan, Atike Pinar-
dc.contributor.authorDemirci, Umut-
dc.contributor.authorYasar, Alper-
dc.contributor.authorBayoglu, Ibrahim Vedat-
dc.contributor.authorHizal, Mutlu-
dc.contributor.authorGulbagci, Burcu-
dc.contributor.authorPaksoy, Nail-
dc.contributor.authorYilmaz, Funda-
dc.contributor.authorDogan, Ozlem-
dc.contributor.authorOrhan, Sibel Oyucu-
dc.contributor.authorKayikcioglu, Erkan-
dc.contributor.authorAytac, Ali-
dc.contributor.authorKeskinkilic, Merve-
dc.contributor.authorMocan, Eda Eylemer-
dc.contributor.authorUnal, Olcun Umit-
dc.contributor.authorAydin, Esra-
dc.contributor.authorYucel, Hakan-
dc.contributor.authorIsik, Deniz-
dc.contributor.authorEren, Onder-
dc.contributor.authorUluc, Basak Oyan-
dc.contributor.authorOzcelik, Melike-
dc.contributor.authorHacibekiroglu, Ilhan-
dc.contributor.authorAydiner, Adnan-
dc.contributor.authorDemir, Hacer-
dc.contributor.authorOksuzoglu, Berna-
dc.contributor.authorCilbir, Ebru-
dc.contributor.authorCubukcu, Erdem-
dc.contributor.authorCetin, Bulent-
dc.contributor.authorOktay, Esin-
dc.contributor.authorErol, Cihan-
dc.contributor.authorOkutur, Sadi Kerem-
dc.contributor.authorYildirim, Nilgun-
dc.contributor.authorAlkan, Ali-
dc.contributor.authorSelcukbiricik, Fatih-
dc.contributor.authorAksoy, Asude-
dc.contributor.authorKarakas, Yusuf-
dc.contributor.authorOzkanli, Gulhan-
dc.contributor.authorDuman, Berna Bozkurt-
dc.contributor.authorAydin, Dincer-
dc.contributor.authorDulgar, Ozgecan-
dc.contributor.authorEr, Muhammed Muhiddin-
dc.contributor.authorTeker, Fatih-
dc.contributor.authorYavuzsen, Tugba-
dc.contributor.authorAykan, Musa Baris-
dc.contributor.authorInal, Ali-
dc.contributor.authorIriagac, Yakup-
dc.contributor.authorKalkan, Nurhan Onal-
dc.contributor.authorKeser, Murat-
dc.contributor.authorSakalar, Teoman-
dc.contributor.authorKut, Engin-
dc.contributor.authorBilgin, Burak-
dc.contributor.authorKaraoglanoglu, Muge-
dc.contributor.authorSunar, Veli-
dc.contributor.authorOzdemir, Ozlem-
dc.contributor.authorTurhal, Nazim Serdar-
dc.contributor.authorKaradurmus, Nuri-
dc.contributor.authorYalcin, Bulent-
dc.contributor.authorSendur, Mehmet Ali Nahit-
dc.date.accessioned2023-06-13T19:10:13Z-
dc.date.available2023-06-13T19:10:13Z-
dc.date.issued2023-
dc.identifier.issn1479-6694-
dc.identifier.issn1744-8301-
dc.identifier.urihttps://doi.org/10.2217/fon-2022-1287-
dc.identifier.urihttps://hdl.handle.net/11499/51149-
dc.descriptionArticle; Early Accessen_US
dc.description.abstractBackground: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative metastatic breast cancer. Methods: The authors report retrospective real-life data for 600 patients with estrogen receptor- and/or progesterone receptor-positive and HER2-negative metastatic breast cancer who were treated with ribociclib and palbociclib in combination with letrozole. Results & conclusion: The results demonstrated that the combination of palbociclib or ribociclib with letrozole has similar progression-free survival and overall survival benefit in real life for the patient group with similar clinical features. Specifically, endocrine sensitivity may be a factor to be considered in the treatment preference.en_US
dc.language.isoenen_US
dc.publisherFuture Medicine Ltden_US
dc.relation.ispartofFuture Oncologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCDK 4en_US
dc.subject6 inhibitorsen_US
dc.subjectHER2-negative metastatic breast canceren_US
dc.subjectHR-positiveen_US
dc.subjectletrozoleen_US
dc.titleTreatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast canceren_US
dc.typeArticleen_US
dc.departmentPamukkale Universityen_US
dc.authoridOrhan, Sibel Oyucu/0000-0001-8217-3471-
dc.authoridPaksoy, Nail/0000-0003-4636-2595-
dc.authoridErul, Enes/0000-0002-2487-2087-
dc.authoridBayram, Ertugrul/0000-0001-8713-7613-
dc.authoridSahin, Elif/0000-0002-1976-3951-
dc.authoridDavarci, Sena Ece-
dc.authoridMenekse, Serkan-
dc.identifier.doi10.2217/fon-2022-1287-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid56960020000-
dc.authorscopusid57223009128-
dc.authorscopusid57202053776-
dc.authorscopusid55349813400-
dc.authorscopusid57226407427-
dc.authorscopusid35329601700-
dc.authorscopusid57439077000-
dc.authorwosidOrhan, Sibel Oyucu/AAJ-8314-2021-
dc.authorwosidPaksoy, Nail/HKF-3015-2023-
dc.authorwosidErul, Enes/GQH-6479-2022-
dc.identifier.pmid37133230en_US
dc.identifier.scopus2-s2.0-85159731947en_US
dc.identifier.wosWOS:000991646700001en_US
dc.institutionauthor…-
dc.identifier.scopusqualityQ1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

6
checked on Nov 16, 2024

WEB OF SCIENCETM
Citations

5
checked on Nov 21, 2024

Page view(s)

66
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.